165 related articles for article (PubMed ID: 8732090)
21. Ki-ras oncogene and p53 tumour suppressor gene mutations in colorectal carcinomas from the European Saar-Luxembourg region are less frequent than predicted by the classic adenoma-carcinoma sequence model.
Pauly M; Schmitz M; Kayser I; Türeci O; Lagoda P; Seitz G; Dicato M
Eur J Cancer; 1997 Nov; 33(13):2265-72. PubMed ID: 9470817
[TBL] [Abstract][Full Text] [Related]
22. [Relations between p53 and p185 expression and prognosis of patients with colon cancers].
Hu J; Wang Z; Jiang Y
Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):247-9. PubMed ID: 9387311
[TBL] [Abstract][Full Text] [Related]
23. Detection of genetic alterations in the p53 suppressor gene and the K-ras oncogene among different grades of dysplasia in patients with colorectal adenomas.
Hosaka S; Aoki Y; Akamatsu T; Nakamura N; Hosaka N; Kiyosawa K
Cancer; 2002 Jan; 94(1):219-27. PubMed ID: 11815980
[TBL] [Abstract][Full Text] [Related]
24. K-ras and p53 mutations and overexpressions as prognostic factors in female rectal carcinoma.
Hirvikoski P; Auvinen A; Servomaa K; Kiuru A; Rytömaa T; Makkonen K; Kosma VM
Anticancer Res; 1999; 19(1B):685-91. PubMed ID: 10216477
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical detection of RAS, JUN, FOS, and p53 oncoprotein expression in human colorectal adenomas and carcinomas.
Magrisso IJ; Richmond RE; Carter JH; Pross CB; Gilfillen RA; Carter HW
Lab Invest; 1993 Dec; 69(6):674-81. PubMed ID: 8264230
[TBL] [Abstract][Full Text] [Related]
26. [Point mutations of N-ras oncogene and abnormal expression of rasp21, p53 proteins in orbital rhabdomyosarcoma].
Zhang H; Song G; Zhang S; Chang J; Zhang W; Yu H
Zhonghua Yan Ke Za Zhi; 2000 Jul; 36(4):267-9, 16. PubMed ID: 11853610
[TBL] [Abstract][Full Text] [Related]
27. Relationship between overexpression of ras p21 oncoprotein and K-ras codon 12 and 13 mutations in Turkish colorectal cancer patients.
Akkiprik M; Celikel CA; Düşünceli F; Sönmez O; Güllüoğlu BM; Sav A; Ozer A
Turk J Gastroenterol; 2008 Mar; 19(1):22-7. PubMed ID: 18386236
[TBL] [Abstract][Full Text] [Related]
28. [Detection of Ki-ras oncogene mutations in normal mucosa, adenoma and adenocarcinoma of the colon].
Wang ZY
Zhonghua Bing Li Xue Za Zhi; 1993 Dec; 22(6):333-6. PubMed ID: 7913419
[TBL] [Abstract][Full Text] [Related]
29. [Quantitative studies of oncogene ras P21 and P53 gene protein expression in the benign and malignant pleomorphic adenomas of salivary gland].
Wang J; Dong F; Wang X
Zhonghua Kou Qiang Yi Xue Za Zhi; 1997 Jul; 32(4):208-11. PubMed ID: 10680505
[TBL] [Abstract][Full Text] [Related]
30. Oncogenic potential of c-erbB-2 and its association with c-K-ras in premalignant and malignant lesions of the human uterine endometrium.
Manavi M; Bauer M; Baghestanian M; Berger A; Kucera E; Pischinger K; Battistutti W; Czerwenka K
Tumour Biol; 2001; 22(5):299-309. PubMed ID: 11553860
[TBL] [Abstract][Full Text] [Related]
31. [Apoptosis and expression of its regulating genes in adenoma and adenocarcinoma of large intestine].
Sun B; Zhang N; Zhao X
Zhonghua Bing Li Xue Za Zhi; 1997 Jun; 26(3):137-40. PubMed ID: 10072852
[TBL] [Abstract][Full Text] [Related]
32. Activation of the ras genes in malignant and premalignant colorectal tumors.
Glarakis IS; Savva S; Spandidos DA
Oncol Rep; 1998; 5(6):1451-4. PubMed ID: 9769386
[TBL] [Abstract][Full Text] [Related]
33. [Expression and mutation of p53 and H-ras genes in the carcinogenesis and development of gastric adenocarcinoma induced by MNNG in rats].
Meng Z; Lei D; Wang J
Zhonghua Bing Li Xue Za Zhi; 1998 Apr; 27(2):117-9. PubMed ID: 11244961
[TBL] [Abstract][Full Text] [Related]
34. Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer.
Schneider PM; Praeuer HW; Stoeltzing O; Boehm J; Manning J; Metzger R; Fink U; Wegerer S; Hoelscher AH; Roth JA
Br J Cancer; 2000 Aug; 83(4):473-9. PubMed ID: 10945494
[TBL] [Abstract][Full Text] [Related]
35. Genetic events in sporadic colorectal adenomas: K-ras and p53 heterozygous mutations are not sufficient for malignant progression.
De Benedetti L; Varesco L; Pellegata NS; Losi L; Gismondi V; Casarino L; Sciallero S; Bonelli L; Biticchi R; Bafico A
Anticancer Res; 1993; 13(3):667-70. PubMed ID: 8317895
[TBL] [Abstract][Full Text] [Related]
36. APC and p53 mutations in de novo colorectal adenocarcinomas.
Aoki T; Takeda S; Yanagisawa A; Kato Y; Ajioka Y; Watanabe H; Kudo S; Nakamura Y
Hum Mutat; 1994; 3(4):342-6. PubMed ID: 8081386
[TBL] [Abstract][Full Text] [Related]
37. [Immunohistochemical expression of p53 oncoprotein in large bowel adenomas and carcinomas].
Roa JC; Villaseca MA; Roa I; Araya JC; Okayasu I; Flores P; Flores M
Rev Med Chil; 1997 May; 125(5):523-9. PubMed ID: 9497572
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of K-ras mutations, ras oncoprotein, and c-erb B-2 oncoprotein expression in adenocarcinoma of the lung.
Nemunaitis J; Klemow S; Tong A; Courtney A; Johnston W; Mack M; Taylor W; Solano M; Stone M; Mallams J; Mues G
Am J Clin Oncol; 1998 Apr; 21(2):155-60. PubMed ID: 9537203
[TBL] [Abstract][Full Text] [Related]
39. K-ras exon 4A has a tumour suppressor effect on carcinogen-induced murine colonic adenoma formation.
Luo F; Ye H; Hamoudi R; Dong G; Zhang W; Patek CE; Poulogiannis G; Arends MJ
J Pathol; 2010 Apr; 220(5):542-50. PubMed ID: 20087880
[TBL] [Abstract][Full Text] [Related]
40. Mutations of Ki-ras and p53 genes in colorectal cancer and their prognostic significance.
Morrin M; Kelly M; Barrett N; Delaney P
Gut; 1994 Nov; 35(11):1627-31. PubMed ID: 7828987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
